Intravenous arginine vasopressin infusion in refractory vasodilatory shock: A clinical study

Indian Journal of Pediatrics

Volumn 79, Issue 4, 2012, Pages 488-493

  Agrawal, Amit ^a,c   Singh, Vishal K ^b   Varma, Amit ^b   Sharma, Rajesh ^b  

^a Chirayu Medical College and Hospital   (India)

^b ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^c Fortis and Escorts Heart Institute and Research Centre ^*  (India)

Author keywords

Inotrope; Pediatric; Refractory hypotension; Vasodilatory shock; Vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; BILIRUBIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; LACTIC ACID; MILRINONE; NORADRENALIN; SODIUM;

ABDOMINAL DISTENSION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; GRAM NEGATIVE SEPSIS; HEART LEFT ATRIUM PRESSURE; HEART OUTPUT; HEART SURGERY; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INFANT; ISCHEMIA; KIDNEY PERFUSION; MEAN ARTERIAL PRESSURE; NECROTIZING ENTEROCOLITIS; NONHUMAN; OUTCOME ASSESSMENT; PERFUSION; POSTOPERATIVE CARE; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SHOCK; SIDE EFFECT; SODIUM BLOOD LEVEL; SURVIVAL; THROMBOCYTE COUNT; TREATMENT DURATION; VASODILATORY SHOCK;

EID: 84862898324     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-011-0557-z     Document Type: Article

References (29)

1. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588-95.
2. Prielipp RC, Butterworth J. Cardiovascular failure and pharmacologic support of the peripheral vasculature after cardiac surgery. New Horiz. 1999;7:472-88. (Pubitemid 30032846)
3. The American Heart Association in Collaboration with the International Liaison Committee on Resuscitation (ILCOR). Part 6: Advanced cardiovascular life support. Section 6: Pharmacology II: agents to optimize cardiac output and blood pressure. Resuscitation. 2000;46:55-62.
4. Farand P, Hamel M, Lauzier F, Plante GE, Lesur O. Organ perfusion/permeability-related effects of norepinephrine and vasopressin in sepsis. Can J Anesth. 2006;53:934-46. (Pubitemid 44710260)
5. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-5. (Pubitemid 27097820)
6. Landry DW. Vasopressin deficiency and hypersensitivity in vasodilatory shock: discovery of a new clinical syndrome. P&S Med Rev. 1996;3:3-4.
7. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25:1279-82. (Pubitemid 27347289)
8. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116:973-80. (Pubitemid 28553541)
9. Luckner G, Dünser MW, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med. 2005;33:2659-66. (Pubitemid 41682122)
10. Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313-9. (Pubitemid 36578501)
11. Efrati O, Modan-Moses D, Vaedi A, Matok I, Bazilay Z, Paret G. Intravenous arginine vasopressin in critically ill children: is it beneficial? Shock. 2004;22:213-7. (Pubitemid 39468984)
12. Masutani S, Senzaki H, Ishido H, et al. Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int. 2005;47:132-6. (Pubitemid 40545413)
13. Rosenzweig EB, Starc TJ, Chen JM, et al. Intravenous arginine vasopressin infusions in children with vasodilatory shock after cardiac surgery. Circulation. 1999;100:II182-6. (Pubitemid 29523532)
14. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 2001;27:1416-21. (Pubitemid 32758942)
15. Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L. Argininevasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Criti Care. 2006;10:R71.
16. Rodríguez-Núñnez A, López-Herce J, Gíl-Antón J, Hernández A, Rey C, RETSPED Working Group of the Spanish Society of Pediatric Intensive Care. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care. 2006;10:R20.
17. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definition for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
18. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92:2226-35.
19. Kulik TJ, Moler FW, Palmisano JM, et al. Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery. Circulation. 1996;94:II63-8. (Pubitemid 26363367)
20. Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg. 2000;15:347-53. (Pubitemid 32977031)
21. Wakatsuki T, Nakaya Y, Inoue I. Vasopressin modulates potassium channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol. 1992;263:H491-6.
22. Lechner E, Hofer A, Mair R, et al. Arginine vasopressin in neonates with vasodilatory shock after cardio pulmonary bypass. Eur J Pediatr. 2007;166:1221-7. (Pubitemid 350029471)
23. Meyer S, Gortner L, McGuire W, Baghai A, Gottschling S. Vasopressin in catecholamine-refractory shock in children. Anaesthesia. 2008;63:228-34. (Pubitemid 351257781)
24. Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine resistant shock in children. Intensive Care Med. 2008;34:511-7. (Pubitemid 351623035)
25. Russell JA, Walley KR, Gordon AC, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877-87. (Pubitemid 351397087)
26. Choong K, Bohn D, Fraser DD, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009;180:632-9.
27. Jerath N, Frndova H, McCrindle BW, Gurofsky R, Humpl T. Clinical Impact of Vasopressin infusion on heamodynamics, liver and renal functions in pediatric patients. Intensive Care Med. 2008;34:1247-80.
28. Dünser MW, Mayr AJ, Ulmer H, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001;93:7-11.
29. Dünser MW, Fries DR, Schobers-berger W, et al. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with multiorgan dysfunction syndrome? Anesth Analg. 2004;99:201-6. (Pubitemid 38808191)